Ja. Eastham et al., SURGICAL RESECTION IN PATIENTS WITH NONSEMINOMATOUS GERM-CELL TUMOR WHO FAIL TO NORMALIZE SERUM TUMOR-MARKERS AFTER CHEMOTHERAPY, Urology, 43(1), 1994, pp. 74-80
Objective. Patients with high-stage nonseminomatous germ cell tumors t
reated with platinum-based chemotherapy who have residual radiographic
evidence of disease and fail to normalize tumor markers present a dif
ficult clinical dilemma. Some authors feel that these patients are not
appropriate surgical candidates. Our practice has been to offer certa
in patients salvage surgery in an attempt for cure, this report is des
igned to review that experience and critically analyze the results. Me
thod. We report a series of 16 such patients with advanced-stage nonse
minomatous germ tell tumors who had persistently elevated alpha fetopr
otein and/or human chorionic gonadotropin. All underwent resection of
all radiographically evident sites of residual disease following induc
tion or salvage chemotherapy. Results. Ten patients had only retroperi
toneal (RP) metastasis. Six patients had more than one site of residua
l disease-4 RP and lung, 2 RP and liver. There were no postoperative d
eaths. The mean postoperative stay was eleven days (range 7 to 36 days
). Six patients (37%) are alive and free of disease at a mean of seven
ty-four months following surgery (range 20 to 145 months). Five had RP
disease only. Ten patients died of disease at a mean of eight months
postoperatively (range 5 to 21 months). Conclusions. Patients with adv
anced nonseminomatous germ cell tumor who fail to normalize their seru
m tumor markers after adequate platinum-based chemotherapy should be c
onsidered for surgical resection of all radiographically evident resid
ual disease. In select cases this practice offers the only viable chan
ce for cure.